TEACHERS ADVISORS, LLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$502,000
+16.2%
148,843
+0.5%
0.00%0.0%
Q4 2018$432,000
-73.3%
148,115
-43.6%
0.00%0.0%
Q3 2018$1,616,000
+67.5%
262,496
+100.7%
0.00%0.0%
Q2 2018$965,000
+74.8%
130,786
+55.4%
0.00%0.0%
Q1 2018$552,000
-21.8%
84,160
+0.3%
0.00%0.0%
Q4 2017$706,000
-26.2%
83,921
+1.3%
0.00%0.0%
Q3 2017$957,000
+3.1%
82,883
+4.3%
0.00%0.0%
Q2 2017$928,000
+110.4%
79,471
+122.3%
0.00%0.0%
Q1 2017$441,000
-9.1%
35,748
+0.4%
0.00%0.0%
Q4 2016$485,000
-27.8%
35,608
+5.5%
0.00%0.0%
Q3 2016$672,000
+53.4%
33,7640.0%0.00%0.0%
Q2 2016$438,000
+284.2%
33,764
+177.9%
0.00%
Q1 2016$114,000
-53.7%
12,1510.0%0.00%
Q4 2015$246,000
+39.0%
12,1510.0%0.00%
Q3 2015$177,000
-31.4%
12,1510.0%0.00%
Q2 2015$258,000
+35.1%
12,151
+47.2%
0.00%
Q1 2015$191,0008,2540.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$3,070,0000.79%
X-Square Capital, LLC 109,832$321,0000.25%
KNOTT DAVID M 111,427$325,0000.15%
ARK Investment Management 1,033,491$3,018,0000.12%
Baker Brothers Advisors 2,677,818$7,819,0000.06%
HARVEY CAPITAL MANAGEMENT INC 31,200$91,0000.05%
DAFNA Capital Management LLC 30,000$88,0000.04%
WASATCH ADVISORS LP 953,368$2,784,0000.04%
FRANKLIN STREET ADVISORS INC /NC 51,415$150,0000.02%
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$2,920,0000.02%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders